| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
0.477 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
JAK1 |
|
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.477 |
Evidence |
|
| PLCG2 |
PLCG2: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.477 |
Evidence |
|